Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study

BACKGROUND: Efficacy of stereotactic body radiotherapy (SBRT) in stage I non–small-cell lung cancer (NSCLC) has almost been established. In Japan, the protocol of 48 Gy in 4 fractions over 4 days has been most often employed, but higher doses may be necessary to control large tumors. Previously, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyakawa, Akifumi, Shibamoto, Yuta, Baba, Fumiya, Manabe, Yoshihiko, Murai, Taro, Sugie, Chikao, Yanagi, Takeshi, Takaoka, Taiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594596/
https://www.ncbi.nlm.nih.gov/pubmed/28893300
http://dx.doi.org/10.1186/s13014-017-0888-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594596/
https://www.ncbi.nlm.nih.gov/pubmed/28893300
http://dx.doi.org/10.1186/s13014-017-0888-7

Ejemplares similares